Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Lisata Therapeutics Expands Intellectual Property Portfolio with New Composition of Matter Patent for Certepetide
-
Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025
-
GoodSAM Foods Hires Thrive Market Veteran James Ren as Vice President of Revenue and Growth to Scale and Advance Mission of Food System Transformation
-
Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization
-
Etex strengthens Latin American presence with EUR 65 million investments in plasterboard production
-
Southern Sky Home Buyers Publishes New Article on ‘The Best Way to Sell Your House Fast In Knoxville: The Benefits of Cash Home Buyers’
-
A State Department of Transportation (DOT) Has Entered Into A Formal Contractual Agreement To Evaluate ProStar’s PointMan
-
AI Changes Ripple's XRP Mining, PFMCrypto Launches AI-Enhanced XRP Cloud Mining with Daily Rewards
-
Polyrizon Retains Nasdaq Listing Following Hearings Panel
-
Lori Murphy Appointed as First Board Member of GoodBrand Impact
-
IRS Commissioner Billy Long to Address Tax Professionals at Tax Summit in Salt Lake City
-
Landstar to Release Second Quarter Results on Tuesday, July 29, 2025
-
BSTR Miner Cloud Mining Unveils Industry-First XRP Mining Service: Zero-Hardware Cloud Solution to Earn Ripple Network Rewards
-
Neo Pepe Coin ($NEOP) Announces Massive Giveaway, Rewarding Early Community Members
-
SELLAS Meets All Primary Endpoints in Phase 2 Trial of SLS009 in r/r AML and Receives FDA Guidance to Advance into First-Line Therapy Study
-
Sky Quarry Announces Strategic Digital Asset Initiative
-
Hengrui Pharma and Kailera Therapeutics Report Positive Topline Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531
-
Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer
-
Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025
-
Neuronetics Appoints New Chief Financial Officer
-
Plus Therapeutics Presents ReSPECT-LM Clinical Trial Results for REYOBIQ™ in Patients with Leptomeningeal Metastases
-
WestKam Gold Corp. Provides Update on Management Cease Trade Order, Announces Appointment of Interim CFO and Announces Private Placement
-
ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel
-
BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer
-
ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area
-
Nexxen Expected to Expand its CTV OEM Relationships and ACR Data Reach in Europe Through Vestel’s Strategic Partnership with VIDAA
-
Maryland Supreme Court Affirms MSP Recovery’s Assignments, Paving the Way for Class Action Lawsuit Against GEICO
-
Aurora Spine Announces Participation in 7th Annual American Society of Pain & Neuroscience Conference
-
Aurora Spine Announces Participation in 7th Annual American Society of Pain & Neuroscience Conference
-
Mirasol Signs Agreement for the Sale of the Nord Projects in Chile for US$2.5 Million Plus Royalty
-
60 Degrees Pharmaceuticals Defines Potential Human Babesiosis Market Size for ARAKODA® (tafenoquine): Annual Max TAM, Sales of $245 Million; Cumulative through Patent Expiration, $1.1 Billion
-
Goodfood to Report Third Quarter Results of Fiscal 2025
-
Pure Sunfarms Publishes First-Of-Its-Kind Cannabis Potency Research in Scientific Reports
-
Cutting Through the Noise: New Podcast “Trade Talks with M4Markets” Brings Real Conversations to Traders Worldwide
-
TopBuild Completes Progressive Roofing Acquisition
-
Presenting on Emerging Growth Conference 84 Day 1 on July 16; Register to live stream
-
ACAMS Launches Enhanced CAMS Certification to Combat Evolving Financial Crime
-
First Steakholder-Formulated Plant-Based Fish Products Rolled Out in Retail Outlets
-
PyroGenesis Announces Completion of Coke-Oven Gas Valorization and Hydrogen Production Project for Tata Steel
-
Accelsius Brings NeuCool™ to Equinix’s Co-Innovation Facility in Ashburn
-
Enthusiast Gaming Announces the Launch of First-to-Market “LookBuilder” Tool for The Sims Resource
-
Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2025 Financial Results
-
Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film
-
Verano Announces Promotion and Appointment of James Leventis as Chief Strategy and Compliance Officer
-
Apellis Announces Five Abstracts Accepted for Oral Presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting
-
AAVantgarde Receives FDA Clearance to Progress Stargardt Disease Asset, AAVB-039, into CELESTE, a Phase 1/2 Clinical Trial
-
Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA
-
Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery™ Therapy for Alzheimer’s Disease
-
AAFA Names Matthew Greenhawt Chief Medical Officer
-
Addgene Announces Strategic Partnership with Promega to Launch Plasmid Collection
